Identifying neonatal early-onset sepsis test and treatment decision thresholds.


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
06 2021
Historique:
received: 11 08 2020
accepted: 01 02 2021
revised: 06 12 2020
pubmed: 3 3 2021
medline: 9 10 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

To derive testing and treatment thresholds for early-onset neonatal sepsis and compare them to thresholds used in the Kaiser-Permanente (KP) Sepsis Calculator. Using surveys distributed in the United States, Brazil and Italy, decision thresholds were derived via self-identified thresholds selected from structured lists (Method 1), and based on clinical vignette responses for testing and treatment with or without inclusion of associated relative risk (Methods 2 and 3). Using Method 1, both testing and treatment thresholds were higher than the KP calculator thresholds. Test thresholds were lower (Method 2) or equivalent (Method 3) to KP using clinical vignettes. No vignette reached the 50% cutoff necessary to define a treatment threshold. The test threshold used by the KP calculator is the same as the threshold chosen by clinicians given a vignette and risk estimate. The KP treatment threshold is lower than that derived using all 3 methods.

Identifiants

pubmed: 33649440
doi: 10.1038/s41372-021-00981-3
pii: 10.1038/s41372-021-00981-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1278-1284

Références

Puopolo KM, Benitz WE, Zaoutis TE, AAP Committee on Fetus and Newborn, AAP Committee on Infectious Diseases. Management of neonates born at ≥35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142:e20182894.
doi: 10.1542/peds.2018-2894
Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30:937–41.
doi: 10.1097/INF.0b013e318223bad2
Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127:817–26.
doi: 10.1542/peds.2010-2217
Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59:1–36.
pubmed: 21088663
Mukhopadhyay S, Eichenwald EC, Puopolo KM. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol. 2013;33:198–205.
doi: 10.1038/jp.2012.96
Kuzniewicz MW, Walsh EM, Li S, Fischer A, Escobar GJ. Development and implementation of an early-onset sepsis calculator to guide antibiotic management in late preterm and term neonates. Jt Comm J Qual Patient Saf. 2016;42:232–9.
pubmed: 27066927
Stinson LF, Payne MS, Keelan JA. Planting the seed: origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota. Crit Rev Microbiol. 2017;43:352–69.
doi: 10.1080/1040841X.2016.1211088
Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008;121:689–96.
doi: 10.1542/peds.2007-2171
Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271:703–7.
doi: 10.1001/jama.1994.03510330081039
Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N. Engl J Med. 1980;302:1109–17.
doi: 10.1056/NEJM198005153022003
Whiting PF, Davenport C, Jameson C, Burke M, Sterne JA, Hyde C, et al. How well do health professionals interpret diagnostic information? A systematic review. BMJ Open. 2015;5:e008155.
doi: 10.1136/bmjopen-2015-008155
Dolan JG, Bordley DR, Mushlin AI. An evaluation of clinicians’ subjective prior probability estimates. Med Decis Mak. 1986;6:216–23.
doi: 10.1177/0272989X8600600406
Iroh Tam PY, Bendel CM. Diagnostics for neonatal sepsis: current approaches and future directions. Pediatr Res. 2017;82:574–83.
doi: 10.1038/pr.2017.134
Kaiser Permanente Sepsis Calculator. https://neonatalsepsiscalculator.kaiserpermanente.org/ . Accessed June 6 2019.
Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics. 2011;128:e1155–63.
doi: 10.1542/peds.2010-3464
Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, et al. Stratification of risk of early-onset sepsis in newborns >/= 34 weeks’ gestation. Pediatrics. 2014;133:30–6.
doi: 10.1542/peds.2013-1689
Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–71.
doi: 10.1001/jamapediatrics.2016.4678
Cahan A, Gilon D, Manor O, Paltiel O. Probabilistic reasoning and clinical decision-making: do doctors overestimate diagnostic probabilities? QJM. 2003;96:763–9.
doi: 10.1093/qjmed/hcg122
Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Helping doctors and patients make sense of health statistics. Psychol Sci Public Interest. 2007;8:53–96.
doi: 10.1111/j.1539-6053.2008.00033.x
Croskerry P. From mindless to mindful practice-cognitive bias and clinical decision making. N. Engl J Med. 2013;368:2445–8.
doi: 10.1056/NEJMp1303712
Croskerry P. A universal model of diagnostic reasoning. Acad Med. 2009;84:1022–8.
doi: 10.1097/ACM.0b013e3181ace703
Mhaskar RS, Wao H, Mahony H, Kumar A, Djulbegovic B. Concordance between decision analysis and matching systematic review of randomized controlled trials in assessment of treatment comparisons: a systematic review. BMC Med Inf Decis Mak. 2014;14:57.
doi: 10.1186/1472-6947-14-57
Ebell MH, Locatelli I, Senn N. A novel approach to the determination of clinical decision thresholds. Evid Based Med. 2015;20:41–7.
doi: 10.1136/ebmed-2014-110140
Boland MV, Lehmann HP. A new method for determining physician decision thresholds using empiric, uncertain recommendations. BMC Med Inf Decis Mak. 2010;10:20.
doi: 10.1186/1472-6947-10-20
Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA, et al. Quantifying uncertainty: physicians’ estimates of infection in critically ill neonates and children. Clin Infect Dis. 2004;38:1383–90.
doi: 10.1086/420741
Burkell J. What are the chances? Evaluating risk and benefit information in consumer health materials. J Med Libr Assoc. 2004;92:200–8.
pubmed: 15098049 pmcid: 385301
Phelps MA, Levitt MA. Pretest probability estimates: a pitfall to the clinical utility of evidence-based medicine? Acad Emerg Med. 2004;11:692–4.
doi: 10.1111/j.1553-2712.2004.tb02416.x
Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med. 1992;92:121–4.
doi: 10.1016/0002-9343(92)90100-P
Evans SC, Roberts MC, Keeley JW, Blossom JB, Amaro CM, Garcia AM, et al. Vignette methodologies for studying clinicians’ decision-making: validity, utility, and application in ICD-11 field studies. Int J Clin Health Psychol. 2015;15:160–70.
doi: 10.1016/j.ijchp.2014.12.001
Cotten CM. Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsis. Clin Perinatol. 2015;42:195–206.
doi: 10.1016/j.clp.2014.10.007
Achten NB, Klingenberg C, Benitz WE, Stocker M, Schlapbach LJ, Giannoni E, et al. Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety: a systematic review and meta-analysis. JAMA Pediatr. 2019;173:1032–40.
doi: 10.1001/jamapediatrics.2019.2825
Kravitz RL, Duan N, Braslow J. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q. 2004;82:661–87.
doi: 10.1111/j.0887-378X.2004.00327.x
Morris R, Jones S, Banerjee S, Collinson A, Hagan H, Walsh H, et al. Comparison of the management recommendations of the Kaiser Permanente neonatal early-onset sepsis risk calculator (SRC) with NICE guideline CG149 in infants >/=34 weeks’ gestation who developed early-onset sepsis. Arch Dis Child Fetal Neonatal Ed. 2020;105:581–6.
doi: 10.1136/archdischild-2019-317165
Veloski J, Tai S, Evans AS, Nash DB. Clinical vignette-based surveys: a tool for assessing physician practice variation. Am J Med Qual. 2005;20:151–7.
doi: 10.1177/1062860605274520
Fagerlin A, Ubel PA, Smith DM, Zikmund-Fisher BJ. Making numbers matter: present and future research in risk communication. Am J Health Behav. 2007;31:S47–56.
doi: 10.5993/AJHB.31.s1.7
Noordzij M, van Diepen M, Caskey FC, Jager KJ. Relative risk versus absolute risk: one cannot be interpreted without the other. Nephrol Dial Transpl. 2017;32:ii13–18.
doi: 10.1093/ndt/gfw465
Bibbins-Domingo K, Force USPST. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164:836–45.
doi: 10.7326/M16-0577

Auteurs

Sharla Rent (S)

Duke University Medical Center, Durham, NC, USA. sharla.rent@duke.edu.

Holly Brine (H)

Toledo Children's Hospital, Toledo, OH, USA.

Maria Fernanda de Almeida (MF)

Brazilian Network on Neonatal Research, Sao Paulo, Brazil.

Ruth Guinsburg (R)

Brazilian Network on Neonatal Research, Sao Paulo, Brazil.

Ligia Rugolo (L)

Brazilian Network on Neonatal Research, Sao Paulo, Brazil.

Fabio Mosca (F)

Fondazione IRCCS Ca' Granda Ospedale Maggiore, Milano, Italy.

Daniele Trevisanuto (D)

Universita degli Studi di Padova, Padova, Italy.

Gary Weiner (G)

University of Michigan, Ann Arbor, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH